Authors
Latest:
Pharmacist-Administered ART Adherence Clinic Makes InroadsPharmacists can resolve ART adherence problems to achieve HIV viral suppression
Latest:
Sleep Disorders: Treatment Options for a Tiring ProblemVarious pharmacologic agents are available for sleep disorders, which affect a large portion of the US population.
Latest:
Long-Acting Insulins for the Treatment of Type 2 DiabetesA look at the role of basal insulin in the treatment of type 2 diabetes.
Latest:
The Hidden Adherence Problem: HPV Vaccination Series Completion Is Not as Easy as 1, 2, 3Pharmacists can help improve vaccination completion rates.
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
FDA Approves Alemtuzumab for Relapsing Forms of Multiple SclerosisThe FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
Latest:
Latent Tuberculosis After the Use of EtanerceptTNF-alpha inhibitors are used to treat a number of inflammatory conditions.
Latest:
TXNIP inhibitors: A New Class of Agents for Diabetes TreatmentTXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Latest:
Value-Based Care in Specialty Populations: High-Quality Clinical Management of Home Infusion Hemophilia Patients Reduces Costs, Maintains OutcomesHigh-quality clinical management of home infusion hemophilia patients reduces costs and maintains outcomes.
Latest:
Something Has to Give: Balancing Specialty Drug Cost With ValueThe ever-growing price tag for new specialty drugs is testing the limits of the health care system to afford these revolutionary therapies.
Latest:
An Indian Health Service Ambulatory Care Resident Describes Her ExperienceAn interview with Dr. Kaley Holmstrom, an IHS Ambulatory Care Resident at the Fort Defiance Indian Hospital in Fort Defiance, AZ
Latest:
Local Health Care Partnerships Are Strongly Associated With Successful Enhanced Community Pharmacy ServicesIncorporating community pharmacists into team-based care models is recommended as a strategy for improving health care access and quality while reducing health care costs.
Latest:
How to Treat Common Skin InfectionsHelpful advice for your patients on treating bacterial skin infections.
Latest:
Elotuzumab Combination Therapy Shows Promise in Previously Treated Multiple MyelomaPatients with previously treated multiple myeloma responded well to therapy with the monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone, with a high objective response rate and longer progression-free survival (PFS) in those who received the dose being taken into phase III studies.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Unlocking the Data Gold Mine for Specialty PharmaciesSpecialty pharmacy needs to raise the bar in data management and be ready for tomorrow as well as deliver superior patient care.
Latest:
Emerging Therapies and the Expanding Role of Pharmacists in the Care of Patients with Heart FailureThis Continuing Education activity is supported by an educational grant from Novartis Pharmaceutical Corporation.
Latest:
The Path to Optimizing Telehealth in a Post–COVID-19 WorldThe use of these services in oncology is likely here to stay.
Latest:
Managing Hematologic Cancer Therapies and Reducing COVID-19 RiskIn this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
Latest:
What is Death With Dignity?States are increasingly adopting this law, and pharmacists should educate and prepare themselves to keep patients informed.
Latest:
PCSK9 Inhibitors: Who are the Best Candidates for Therapy?Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.
Latest:
Tyrosine-Kinase Inhibitors Well Tolerated, Despite Lack of Tests in Chronic Myeloid Leukemia Patients With Comorbid ConditionsChronic myeloid leukemia patients likely have comorbid conditions at the time of their diagnosis; however, most tyrosine-kinase inhibitor studies exclude patients with these conditions.
Latest:
Emphasize Medication Adherence to PatientsMethods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
